Who backs Ascend (Drug Discovery)?
13 investors| Investor | Type |
|---|---|
| DCVC | Venture capital |
| Cathay Capital | PE / buyout |
| Digitalis Ventures | Venture capital |
| Deerfield Management | Venture capital |
| DCVC Bio | Venture capital |
| Lingotto | Hedge fund |
| EW Healthcare Partners | Venture capital |
| 4BIO Capital | — |
| Abingworth | — |
| Ajinomoto | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Ascend (Drug Discovery) investors
13 investors are on record for Ascend (Drug Discovery), including DCVC, Cathay Capital, Digitalis Ventures and Deerfield Management. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 private equity firm.
Free account
More of Ascend (Drug Discovery) with a free account
- ·The complete investor list: 13 names
- ·Watch Ascend (Drug Discovery): the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Ascend (Drug Discovery). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View